Researchers
Lazarević, Slavica
Results 1-20 of 59
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Modulation of gliclazide permeability by probiotic bacteria and bile acids: insights from the PAMPA model![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2025 | Gut–Brain Axis and Bile Acid Signaling: Linking Microbial Metabolism to Brain Function and Metabolic Regulation![]() | Stanimirov, Bojan | Article | 21M21 |
| 2025 | Modeling determinants of student knowledge on gut microbiota: a negative binomial regression approach![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2025 | Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment![]() | Lazarevic, Slavica | Article | 21aM21a |
| 2025 | Personalizing inflammatory bowel disease treatment: the emerging role of pharmacomicrobiomics![]() | Lazarević, Slavica | Conference Paper | Mp. category will be shown later |
| 2025 | Influence of probiotics and deoxycholate on azathioprine transport in the PAMPA model: insights into pharmacomicrobiomics and interindividual variability in drug response![]() | Djanic, Maja | Article | 21aM21a |
| 2025 | In Vitro Evaluation of Drug–Drug Interaction Between Gliclazide and Antacids at the Absorption Level![]() | Lazarević, Slavica | Article | 21aM21a |
| 2025 | Parental knowledge, attitudes, and practices on probiotic use in preschool children in Serbia: a cross-sectional study![]() | Danic, Maja | Article | 21M21 |
| 2024 | Bile acids upregulate carbonyl reductase and aldo-keto reductase expression in breast adenocarcinoma cell line following doxorubicin treatment![]() | Stanimirov, Bojan | Conference Paper | Mp. category will be shown later |
| 2024 | Unveiling the Intricacies of Simvastatin Bioaccumulation and Biotransformation in Probiotic Bacteria Model![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2024 | Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites![]() | Đanić, Maja | Article | 21aM21a |
| 2024 | Lekovi u prometu 2024 : priručnik o lekovima i njihovoj primeni![]() | Tomić, Zdenko
Horvat, Olga
| Other | Mp. category will be shown later |
| 2024 | Intestinal microbiota, probiotics and their interactions with drugs: knowledge, attitudes and practices of health science students in Serbia![]() | Djanic, Maja | Article | 21aM21a |
| 2024 | Influence of Bile Acids on Clindamycin Hydrochloride Skin Permeability: In Vitro and In Silico Preliminary Study![]() | Zaklan, Dragana | Article | 22M22 |
| 2023 | Lekovi u prometu 2023 : priručnik o lekovima i njihovoj primeni![]() | Stanulović, Milan
Goločorbin-Kon, Svetlana
| Other | Mp. category will be shown later |
| 2023 | Zaštita intelektualne svojine lekova- uticaj na potrošnju antidijabetika u Srbiji![]() | Prodanović, Dušan | Conference Paper | Mp. category will be shown later |
| 2023 | Influence of probiotics and bile acids on the gliclazide permeation: in vitro PAMPA model study![]() | Pavlović, Nebojša | Conference Paper | Mp. category will be shown later |
| 2023 | Evaluation of the influence of bile acids on clindamycin hydrochloride permeability using in vitro PAMPA skin model![]() | Zaklan, Dragana | Conference Paper | Mp. category will be shown later |
| 2023 | Exploring Simvastatin Bioaccumulation and Biotransformation in Probiotic Bacteria for Enhanced Insight into Drug-Microbiota Interactions![]() | Đanić, Maja | Conference Paper | Mp. category will be shown later |
| 2023 | Bile acids alter clindamycin permeation through the skin: in vitro permeability study![]() | Zaklan, Dragana | Conference Paper | Mp. category will be shown later |
